3-(N-methoxy-N-methylsulfamoyl)benzoic acid | 848290-16-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(N-methoxy-N-methylsulfamoyl)benzoic acid
• 英文别名: 3-{[methoxy(methyl)amino]sulfonyl}benzoic acid；3-[Methoxy(methyl)sulfamoyl]benzoic acid
• CAS: 848290-16-4
• 化学式: C₉H₁₁NO₅S
• mdl: MFCD06655896
• 分子量: 245.256
• InChiKey: XSMWWLKSVJQCRJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  92.3
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
  申请人：AMGEN INC.

  公开号：US20190077793A1

  公开（公告）日：2019-03-14

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

  本发明提供了一种式（I）的化合物或其药学上可接受的盐，包括本发明化合物的药物组合物，制造本发明化合物的方法以及它们的治疗用途。
• QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS
  申请人：Aquila Brian

  公开号：US20090118261A1

  公开（公告）日：2009-05-07

  The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.

  本发明涉及化学式(I)的化合物或其药学上可接受的盐，其具有B Raf抑制活性，因此对其抗癌活性有用，并且在人体或动物体的治疗方法中使用。本发明还涉及制造上述化学化合物的方法，包含它们的制药组合物以及在制造用于在温血动物（如人）中产生抗癌效果的药物中使用它们的用途。
• Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof
  申请人：RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC.

  公开号：EP0339950A2

  公开（公告）日：1989-11-02

  This invention provides certain dibenzofurancar­boxamides as defined by the formula: where R₁ is hydrogen, amino, alkylamino or halo; R₂ is hydrogen, halo, sulfamyl, alkylsulfamyl or alkylsulfonyl; R′ is hydrogen or alkyl or together with a vicinal R′ group may form a double bond; and R is certain specific nitrogen heterocyclic groups. The compounds of the invention are useful as 5HT₃ antagonists having unique CNS, anti-emetic and gastric prokinetic activity void of any significant D₂ receptor binding properties. The invention also provides processes necessary for the preparation of the compounds of the invention.

  本发明提供了某些由式定义的二苯并呋喃甲酰胺： 其中 R₁ 是氢、氨基、烷基氨基或卤素； R₂ 是氢、卤素、氨基磺酰基、烷基氨基磺酰基或烷基磺酰基； R′ 是氢或烷基，或与邻接的 R′基团一起可形成双键；以及 R 是某些特定的氮杂环基团。 本发明化合物可作为 5HT₃ 拮抗剂，具有独特的中枢神经系统、止吐和促胃动力活性，不具有任何明显的 D₂ 受体结合特性。本发明还提供了制备本发明化合物的必要工艺。
• Bisamide sarcomere activating compounds and uses therof
  申请人：AMGEN INC.

  公开号：US10723720B2

  公开（公告）日：2020-07-28

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

  本发明提供了一种式（I）化合物或其药学上可接受的盐、包含本发明化合物的药物组合物、制造本发明化合物的方法及其治疗用途。
• Bisamide sarcomere activating compounds and uses thereof
  申请人：AMGEN INC.

  公开号：US10899746B2

  公开（公告）日：2021-01-26

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

  本发明提供了一种式（I）化合物或其药学上可接受的盐、包含本发明化合物的药物组合物、制造本发明化合物的方法及其治疗用途。